Published in Am J Psychiatry on August 01, 1999
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ (2004) 2.88
A social-attributional analysis of alcohol response. Psychol Bull (2014) 0.89
Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence. Depress Anxiety (2012) 0.84
PTSD symptoms, potentially traumatic event exposure, and binge drinking: a prospective study with a national sample of adolescents. J Anxiety Disord (2011) 0.83
Effects of alcohol on the acquisition and expression of fear-potentiated startle in mouse lines selectively bred for high and low alcohol preference. Psychopharmacology (Berl) (2011) 0.80
An evolutionary perspective on the co-occurrence of social anxiety disorder and alcohol use disorder. J Affect Disord (2016) 0.75
The dawn of Darwinian medicine. Q Rev Biol (1991) 2.35
Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology (1998) 2.26
Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (1989) 1.98
Evaluating measures of family history of alcoholism: density versus dichotomy. Addiction (1998) 1.94
Childhood sexual and physical abuse in adult patients with borderline personality disorder. Am J Psychiatry (1990) 1.80
Borderline personality disorder symptoms and severity of sexual abuse. Am J Psychiatry (1995) 1.65
Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. J Subst Abuse Treat (1998) 1.54
Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry (1994) 1.53
Marital quality and psychological adjustment to widowhood among older adults: a longitudinal analysis. J Gerontol B Psychol Sci Soc Sci (2000) 1.51
Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol Med (1996) 1.49
Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry (1976) 1.38
Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict (1991) 1.33
Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety (1997) 1.27
Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry (1976) 1.21
Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology (1999) 1.13
Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry (2001) 1.11
Emergency medical services outcomes project I (EMSOP I): prioritizing conditions for outcomes research. Ann Emerg Med (1999) 1.08
Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med (1980) 1.08
Alcohol abuse/dependence in motor vehicle crash victims presenting to the emergency department. Acad Emerg Med (1997) 1.08
Awareness and use of hepatitis B vaccine among homosexual male clients of a Boston community health center. Public Health Rep (1990) 1.07
Urinary free cortisol excretion in depression. Psychol Med (1976) 1.04
Assessment of body fat in the pony: part I. Relationships between the anatomical distribution of adipose tissue, body composition and body condition. Equine Vet J (2011) 1.02
Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry (1984) 1.01
Paradoxical response to dopamine agonists in tardive dyskinesia. Am J Psychiatry (1977) 1.01
Evolution and the origins of disease. Sci Am (1998) 1.00
New findings in anxiety. A synthesis for clinical practice in 1985. Psychiatr Clin North Am (1985) 0.99
Gender differences in the relationships among SES, family history of alcohol disorders and alcohol dependence. J Stud Alcohol (1999) 0.96
Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med (1996) 0.96
Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry (1996) 0.96
The relationship between alcohol symptoms and consumption among older drinkers. Alcohol Clin Exp Res (1996) 0.95
Clinical evaluation of resin-bonded bridges: a retrospective study. Quintessence Int (1991) 0.95
Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med (1976) 0.94
Crash characteristics and injuries of victims impaired by alcohol versus illicit drugs. Accid Anal Prev (1997) 0.94
Effect of dietary restriction on body condition, composition and welfare of overweight and obese pony mares. Equine Vet J (2010) 0.93
Identification of novel metabolites of the xenoestrogen 4-tert-octylphenol in primary rat hepatocytes. Chem Biol Interact (2000) 0.92
Emergency physician attitudes concerning intervention for alcohol abuse/dependence delivered in the emergency department: a brief report. J Addict Dis (2000) 0.91
Ages of onset of DSM-III anxiety disorders. Compr Psychiatry (1985) 0.91
Blood-injury-illness phobia: a review. J Clin Psychol (1985) 0.90
Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med (1990) 0.90
Biotransformation of the xenoestrogen 4-tert-octylphenol in hepatocytes of rainbow trout (Oncorhynchus mykiss). Xenobiotica (2000) 0.90
Accounting for differences in estrogenic responses in rainbow trout (Oncorhynchus mykiss: Salmonidae) and roach (Rutilus rutilus: Cyprinidae) exposed to effluents from wastewater treatment works. Environ Sci Technol (2005) 0.90
Cardiac and neuroendocrine responses to exposure therapy in height phobics: desynchrony within the 'physiological response system'. Behav Res Ther (1989) 0.89
Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry (1991) 0.88
Risk factors for anabolic-androgenic steroid use in men. J Psychiatr Res (1995) 0.87
Cholecystokinin-4 and panic. Arch Gen Psychiatry (1990) 0.86
Profiles of environmental and endogenous estrogens in the zebra mussel Dreissena polymorpha. Chemosphere (2007) 0.85
Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry (1994) 0.85
Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment. Biol Psychiatry (1997) 0.85
Injury type, injury severity, and repeat occurrence of alcohol-related trauma in adolescents. Alcohol Clin Exp Res (1994) 0.85
Retentive strength of six temporary dental cements. Quintessence Int (1990) 0.85
Severity and treatment of alcohol withdrawal in elderly versus younger patients. Alcohol Clin Exp Res (1994) 0.84
Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia. Arch Gen Psychiatry (1989) 0.84
Alcohol consumption in relation to other predictors of suicidality among adolescent inpatient girls. J Am Acad Child Adolesc Psychiatry (1993) 0.84
Alcohol abuse among clinically anxious patients. Behav Res Ther (1986) 0.84
Fainting on exposure to phobic stimuli. Am J Psychiatry (1983) 0.84
Dysthymia characteristic of heavy alcohol use in depressed adolescents. Biol Psychiatry (1993) 0.83
The influences of age and gender on blood ethanol concentrations in healthy humans. J Stud Alcohol (1999) 0.83
Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med (1985) 0.83
A comparison of panic disorder and agoraphobia with panic attacks. Compr Psychiatry (1985) 0.83
Treatment outcome of alcoholics with and without cocaine disorders. Alcohol Clin Exp Res (1994) 0.83
Mixtures of estrogenic contaminants in bile of fish exposed to wastewater treatment works effluents. Environ Sci Technol (2005) 0.83
Alpha 2-adrenoreceptor status in obsessive-compulsive disorder. Biol Psychiatry (1990) 0.82
Defense mechanism changes in successfully treated patients with obsessive-compulsive disorder. Am J Psychiatry (1998) 0.82
Group behavioral therapy of obsessive-compulsive disorder: seven vs. twelve-week outcomes. Depress Anxiety (2001) 0.82
Anxiety and cardiovascular reactivity in the Tecumseh population. J Hypertens (1998) 0.82
Panic attacks induced by doxapram. Biol Psychiatry (1993) 0.81
Anxiety and plasma cortisol at the crest of the circadian cycle:reappraisal of a classical hypothesis. Psychosom Med (1978) 0.81
Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology (1987) 0.81
Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology (1996) 0.81
A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behav Res Ther (1991) 0.80
Circadian fluctuation of plasma epinephrine in supine humans. Psychoneuroendocrinology (1987) 0.80
Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res (1985) 0.80
Relative size of the anterior thalamic nuclei differentiates anthropoids by social system. Brain Behav Evol (1987) 0.80
Laboratory exposure to 17beta-estradiol fails to induce vitellogenin and estrogen receptor gene expression in the marine invertebrate Mytilus edulis. Aquat Toxicol (2006) 0.80
A survey of bottled water usage by pediatric dental patients: implications for dental health. Quintessence Int (1989) 0.80
Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology (1988) 0.80
Endocrine function in emotionally disturbed and normal men. J Nerv Ment Dis (1968) 0.79
Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels. Am J Psychiatry (1996) 0.79
Does acute alcohol ingestion and/or chronic alcohol use among motor vehicle crash victims lead to a more complicated hospital course? Annu Proc Assoc Adv Automot Med (2000) 0.79
Assessment of body fat in the pony: part II. Validation of the deuterium oxide dilution technique for the measurement of body fat. Equine Vet J (2011) 0.79
Anxiety induced by flooding therapy for phobias does not elicit prolactin secretory response. Psychosom Med (1980) 0.78
Psychosomatics and chronobiology: possible implications of neuroendocrine rhythms. A review. Psychosom Med (1972) 0.78